These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20346888)

  • 41. Low dose treatment with methotrexate-adverse drug reactions survey.
    Getov I; Dimitrova Z; Petkova V
    Boll Chim Farm; 2000; 139(4):153-8. PubMed ID: 11059096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cotton-wool spots as the initial ocular manifestation in Wegener's granulomatosis.
    Mangouritsas G; Ulbig M
    Ger J Ophthalmol; 1994 Mar; 3(2):68-70. PubMed ID: 8193574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leukemoid reaction after methotrexate-induced pancytopenia in a patient undergoing continuous ambulatory peritoneal dialysis.
    Sun CY; Lin HC; Chen YC; Tsai CR; Wu MS
    Chang Gung Med J; 2006; 29(5):513-7. PubMed ID: 17214397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug.
    Hider SL; Owen A; Hartkoorn R; Khoo S; Back D; Silman AJ; Bruce IN
    Ann Rheum Dis; 2006 Oct; 65(10):1390-3. PubMed ID: 16504991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An update on methotrexate.
    Braun J; Rau R
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H; Ohno S; Ishigatsubo Y
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methotrexate and doxycycline interaction: a rare cause of pancytopenia.
    Arslan A; Zain MA; Mukhtar M; Ullah W; Roomi S
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency.
    Park GT; Jeon DW; Roh KH; Mun HS; Lee CH; Park CH; Kang KW; Kim SM; Kang JM; Park HC
    Korean J Intern Med; 1999 Jan; 14(1):85-7. PubMed ID: 10063319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    Mori S; Hidaka M; Kawakita T; Hidaka T; Tsuda H; Yoshitama T; Migita K; Ueki Y
    PLoS One; 2016; 11(4):e0154744. PubMed ID: 27128679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-dose methotrexate-induced pancytopenia.
    Preet Singh Y; Aggarwal A; Misra R; Agarwal V
    Clin Rheumatol; 2007 Jan; 26(1):84-7. PubMed ID: 16636937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shingles: More than Meets the Eye.
    Komitova RT; Grklanov VA; Lindas KK; Ganeva PV
    Folia Med (Plovdiv); 2019 Mar; 61(1):158-162. PubMed ID: 31237855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis.
    Pu T; Ni Y; Li PH; Yu D; Yu Q; Yu LM
    Am J Med Sci; 2022 Feb; 363(2):185-190. PubMed ID: 34562416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pancytopenia related to low-dose methotrexate: study of five cases and review of the literature].
    Serraj K; Federici L; Maloisel F; Alt M; Andrès E
    Rev Med Interne; 2007 Sep; 28(9):584-8. PubMed ID: 17451848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Severe pancytopenia and stomatitis in a patient treated with low-dose methostraxate].
    Bruggisser M; Rätz Bravo AE; Krähenbühl S
    Praxis (Bern 1994); 2011 Jun; 100(13):765-74; quiz 772. PubMed ID: 21698560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.
    Gutierrez-Ureña S; Molina JF; García CO; Cuéllar ML; Espinoza LR
    Arthritis Rheum; 1996 Feb; 39(2):272-6. PubMed ID: 8849378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methotrexate-induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature.
    Hosseini E; Shahbazi F
    Curr Drug Saf; 2024; 19(2):224-235. PubMed ID: 37194235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature.
    Kurian A; Haber R
    J Cutan Med Surg; 2011; 15(5):275-9. PubMed ID: 21962187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis: comment on the article by Gutierrez-Ureña et al.
    Nygaard H
    Arthritis Rheum; 1997 Jan; 40(1):194-5; author reply 195-6. PubMed ID: 9008620
    [No Abstract]   [Full Text] [Related]  

  • 60. Methotrexate pulmonary toxicity.
    Cannon GW
    Rheum Dis Clin North Am; 1997 Nov; 23(4):917-37. PubMed ID: 9361161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.